"
Cannabis Science
™ works with World Authorities on phytocannabinoid science targeting critical illnesses. Adhering to scientific methodologies to develop, produce, and commercialize phytocannabinoid based pharmaceutical products."
Home
Corporate
Products
Research
Communications
Investors
Contact Us
Saturday February 04, 2012
Breaking News
Overview
News Releases
Breaking News
Media Coverage
White Papers
Newsletters
Blog
Forums
Patient Inquiries
Investors
Partnerships
News Release Subscription
Required *
First Name
*
Field not valid (required or bad value)
Last Name
*
Field not valid (required or bad value)
Email
*
Field not valid (required or bad value)
News Releases
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
Date
1
Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal Reports
Thursday, 02 February 2012
2
Cannabis Science Reports Success For 4th Brand New Self-Administering Cancer Patient
Thursday, 02 February 2012
3
FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side Effects
Wednesday, 01 February 2012
4
Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are Now Pain Free
Monday, 30 January 2012
5
Cancer Patient Success Prompts Cannabis Science To Begin FDA Investigational New Drug (IND) Application Process
Wednesday, 25 January 2012
6
CBIS Updates Latest Remarkable Follow Up Photographs Received from 3rd Cancer Patient
Tuesday, 24 January 2012
7
CBIS Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents Cannabis Extracts Killing Cancerous Tumor
Thursday, 19 January 2012
8
CBIS Reports Apparent Success For 3rd Self-Medicated Cancer Patient
Wednesday, 11 January 2012
9
CBIS Entering A Potential $80bil Cancer Drugs Market
Tuesday, 10 January 2012
10
Medical Marijuana Frontier, Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed as Squamous Cell Carcinoma and Skin Cancer Patients Report Continued Shrinking of Cancer Cells
Friday, 06 January 2012
11
More Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed As Self Medicating Squamous Cell Carcinoma Patient Reports Continued Shrinking of Cancer Tumor
Tuesday, 03 January 2012
12
Cannabis Science Issues Earnings Guidance for 2012 Forecasted at $6,846,000 and Potential Increased to $65,740,000 in 2014 with $0.02 Per Share Positive Earnings
Thursday, 29 December 2011
13
Cannabis Science Brand Releases Worldwide Growth Guidance For Its Formulations Targeting Critical Ailments
Wednesday, 21 December 2011
14
Cannabis Science Reports: Three Former Federal Law Enforcement Agents Want To Legalize Marijuana Through Washington State Initiative 502
Monday, 19 December 2011
15
Cannabis Science Negotiates Commercialization Deal to Bring Cannabis Science Brand Formulations Immediately into the California Market
Wednesday, 14 December 2011
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 1 of 10
Cannabis Science Contact Info | Telephone: 1 888.889.0888 | Fax: 1 866.943.5085 | Email: info@cannabisscience.com
© 2009
Cannabis Science Inc™
(OTCBB: CBIS). All Rights Reserved.
To Top of Page